![MDL Mass Tort & Class Action Monitor](https://harrismartin.s3.amazonaws.com/media/uploads/publications/MDL_CoverImage_1.jpg)
Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
Download a publication order form here or subscribe here.
MDL Mass Tort & Class Action Monitor - Issue: 4
MDL Mass Tort & Class Action Monitor - Issue: 3
Judicial Panel to Decide Motion to Transfer Generic Drug Pricing Antitrust Cases to Coordinated MDL Docket in Pa.
MDL Petitions for Hip Devices, 3T Heater-Cooler, Mirena & Farxiga to be Heard Next Month in Phoenix
Howmedica Opposes Motion to Create LFIT V40 MDL Docket, Says ‘Small Number of Actions’ Doesn’t Justify Coordination
Multi-County Designation Sought for N.J. LFIT Anatomic Cobalt Chromium V40 Femoral Head Cases